Scleroderma Study Offers New Hope For Sufferers
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.
The experimental procedure uses chemotherapy and radiation to destroy the body’s malfunctioning immune system, then replaces it via a stem-cell transplant. The stem cells are taken from the patient’s own blood and given back to the patient after the chemotherapy.
In a multisite clinical trial, the approach proved more successful than the existing treatment, significantly improving survival and reported quality of life. “This is a major advance in the treatment of severe scleroderma,” said Karen Ballen, MD, a co-investigator on the study and the director of stem cell transplantation at the University of Virginia Cancer Center.
New Scleroderma Treatment
The study compared the most effective existing treatment, the drug cyclophosphamide, with the new approach. Thirty-four trial participants received cyclophosphamide, while 33 received the stem cell transplant treatment. After 72 months, 86 percent of those who received the stem-cell transplant remained alive, compared with only 51 percent of those who received infusions of cyclophosphamide.
In the New England Journal of Medicine paper detailing their findings, the researchers conclude: “At four and a half years of follow up, participants who received a transplant experienced significantly better outcomes overall than those who received cyclophosphamide. In addition, 44 percent of participants who received cyclophosphamide had begun taking anti-rheumatic drugs for progression of their scleroderma, compared to only 9 percent of those who received a transplant.”
Both treatment options carried risks of infections and low blood-cell counts, the researchers reported. The overall infection rates were similar.
All participants had severe scleroderma that affected their lungs or kidneys. The researchers noted that their study had limitations that suggest the findings may not apply to all patients with scleroderma.
This article has been republished from materials provided by the University of Virginia Health System. Note: material may have been edited for length and content. For further information, please contact the cited source.
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. Keith M. Sullivan et al. N Engl J Med 2018; 378:35-47January 4, 2018DOI: 10.1056/NEJMoa1703327.
Understanding the Process of Cell DivisionNews
Using multiple techniques such as structural modelling, X-ray scattering, X-ray crystallography and electron microscopy, scientists have found that the Spc110 protein provides a greater function in mitosis originally believed. This information could help understand the process in human cells and the abnormalities that occur in cancer.READ MORE
Mutant Bacteria Show How Changes in Membrane Proteins Affect Cell FunctionsNews
Phospholipids are water insoluble "building blocks" that define the membrane barrier surrounding cells and provide the structural scaffold and environment where membrane proteins reside. Researchers constructed mutants in bacteria and yeast in which the composition of these "building blocks" could be varied and studied how it adversely affected cellular functions.READ MORE
Portable Analysis and Alloy Fingerprints Reveal Secrets of Picasso BronzesNews
Researchers have completed the first major material survey and study of the Musée national Picasso-Paris’ world-renowned Pablo Picasso bronzes using cutting-edge, portable instruments.
Comments | 0 ADD COMMENT
3rd Annual Bioprocessing of Advanced Cellular Therapies
May 29 - May 30, 2018
Next Gen Regenerative Medicine & Tissue Engineering
May 29 - May 30, 2018